4 completed, 1 recruiting, 1 terminated. 5 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow STSA-1002 injection: new trials by email Literature Review of STSA-1002 injection trials Research Report on STSA-1002 injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome STSA-1002 injection, STSA-1002 Injection Placebo - Acute Respiratory Distress Syndrome (ARDS) | Phase 3 | Recruiting | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 406 | 2025-10-31 | 2026-01-02 |
| To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome STSA-1002 Injection Placebo, STSA-1002 Injection - Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | Completed | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 47 | 2023-12-09 | 2025-07-11 |
| A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects STSA-1002 Injection, STSA-1005 Injection - Healthy Subject | Phase 1 | Terminated | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 50 | 2022-11-08 | 2024-05-22 |
| A Study of STSA-1002 in Healthy Subjects STSA-1002 Injection, Placebo - Healthy Subject | Phase 1 | Completed | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 26 | 2022-10-14 | 2023-04-18 |
| The Safety of STSA-1002 Following Intravenous Infusion in Healthy Subjects STSA-1002 injection, Placebo - Healthy | Phase 1 | Completed | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 52 | 2022-01-10 | 2023-12-20 |
| The Safety and Tolerability of STSA-1002 Following Intravenous Infusion in Healthy Subjects STSA-1002 injection, Placebo - Healthy | Phase 1 | Completed | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 40 | 2021-09-28 | 2022-04-11 |
Respiratory Distress Syndrome (2)
Staidson (Beijing) Biopharmaceuticals Co., Ltd (6)
China (5) · United States (1)
Bin Cao, Ph.D (1) · Bin M.D. Cao (1) · Fengxue Guo, Bachelor (1) · Xinghe Wang, Ph.D (1)